Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,527 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quinazolinone-dihydropyrano[3,2-b]pyran hybrids as new α-glucosidase inhibitors: Design, synthesis, enzymatic inhibition, docking study and prediction of pharmacokinetic.
Sherafati M, Mirzazadeh R, Barzegari E, Mohammadi-Khanaposhtani M, Azizian H, Sadegh Asgari M, Hosseini S, Zabihi E, Mojtabavi S, Ali Faramarzi M, Mahdavi M, Larijani B, Rastegar H, Hamedifar H, Hamed Hajimiri M. Sherafati M, et al. Among authors: hosseini s. Bioorg Chem. 2021 Apr;109:104703. doi: 10.1016/j.bioorg.2021.104703. Epub 2021 Feb 8. Bioorg Chem. 2021. PMID: 33609917
Synthesis, characterization, molecular docking, and biological activities of coumarin-1,2,3-triazole-acetamide hybrid derivatives.
Sepehri N, Mohammadi-Khanaposhtani M, Asemanipoor N, Hosseini S, Biglar M, Larijani B, Mahdavi M, Hamedifar H, Taslimi P, Sadeghian N, Gulcin I. Sepehri N, et al. Among authors: hosseini s. Arch Pharm (Weinheim). 2020 Oct;353(10):e2000109. doi: 10.1002/ardp.202000109. Epub 2020 Jul 9. Arch Pharm (Weinheim). 2020. PMID: 32643792
Novel quinazolin-sulfonamid derivatives: synthesis, characterization, biological evaluation, and molecular docking studies.
Sepehri N, Mohammadi-Khanaposhtani M, Asemanipoor N, Hosseini S, Biglar M, Larijani B, Mahdavi M, Hamedifar H, Taslimi P, Sadeghian N, Norizadehtazehkand M, Gulcin I. Sepehri N, et al. Among authors: hosseini s. J Biomol Struct Dyn. 2022 May;40(8):3359-3370. doi: 10.1080/07391102.2020.1847193. Epub 2020 Nov 23. J Biomol Struct Dyn. 2022. PMID: 33222620
Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives.
Pedrood K, Sherafati M, Mohammadi-Khanaposhtani M, Asgari MS, Hosseini S, Rastegar H, Larijani B, Mahdavi M, Taslimi P, Erden Y, Günay S, Gulçin İ. Pedrood K, et al. Among authors: hosseini s. Int J Biol Macromol. 2021 Feb 15;170:1-12. doi: 10.1016/j.ijbiomac.2020.12.121. Epub 2020 Dec 19. Int J Biol Macromol. 2021. PMID: 33352155
The natural-based optimization of kojic acid conjugated to different thio-quinazolinones as potential anti-melanogenesis agents with tyrosinase inhibitory activity.
Sepehri N, Iraji A, Yavari A, Asgari MS, Zamani S, Hosseini S, Bahadorikhalili S, Pirhadi S, Larijani B, Khoshneviszadeh M, Hamedifar H, Mahdavi M, Khoshneviszadeh M. Sepehri N, et al. Among authors: hosseini s. Bioorg Med Chem. 2021 Apr 15;36:116044. doi: 10.1016/j.bmc.2021.116044. Epub 2021 Jan 27. Bioorg Med Chem. 2021. PMID: 33640246
Anti-melanogenesis and anti-tyrosinase properties of aryl-substituted acetamides of phenoxy methyl triazole conjugated with thiosemicarbazide: Design, synthesis and biological evaluations.
Hosseinpoor H, Moghadam Farid S, Iraji A, Askari S, Edraki N, Hosseini S, Jamshidzadeh A, Larijani B, Attarroshan M, Pirhadi S, Mahdavi M, Khoshneviszadeh M. Hosseinpoor H, et al. Among authors: hosseini s. Bioorg Chem. 2021 Sep;114:104979. doi: 10.1016/j.bioorg.2021.104979. Epub 2021 May 11. Bioorg Chem. 2021. PMID: 34140181
Design, synthesis, and α-glucosidase-inhibitory activity of phenoxy-biscoumarin-N-phenylacetamide hybrids.
Ansari S, Azizian H, Pedrood K, Yavari A, Mojtabavi S, Faramarzi MA, Golshani S, Hosseini S, Biglar M, Larijani B, Rastegar H, Hamedifar H, Mohammadi-Khanaposhtani M, Mahdavi M. Ansari S, et al. Among authors: hosseini s. Arch Pharm (Weinheim). 2021 Dec;354(12):e2100179. doi: 10.1002/ardp.202100179. Epub 2021 Aug 31. Arch Pharm (Weinheim). 2021. PMID: 34467580
Design and synthesis of phenoxymethybenzoimidazole incorporating different aryl thiazole-triazole acetamide derivatives as α-glycosidase inhibitors.
Nasli Esfahani A, Iraji A, Alamir A, Moradi S, Asgari MS, Hosseini S, Mojtabavi S, Nasli-Esfahani E, Faramarzi MA, Bandarian F, Larijani B, Hamedifar H, Hajimiri MH, Mahdavi M. Nasli Esfahani A, et al. Among authors: hosseini s. Mol Divers. 2022 Aug;26(4):1995-2009. doi: 10.1007/s11030-021-10310-7. Epub 2021 Sep 13. Mol Divers. 2022. PMID: 34515954 Free PMC article.
Design and synthesis of novel nitrothiazolacetamide conjugated to different thioquinazolinone derivatives as anti-urease agents.
Sohrabi M, Nazari Montazer M, Farid SM, Tanideh N, Dianatpour M, Moazzam A, Zomorodian K, Yazdanpanah S, Asadi M, Hosseini S, Biglar M, Larijani B, Amanlou M, Barazandeh Tehrani M, Iraji A, Mahdavi M. Sohrabi M, et al. Among authors: hosseini s. Sci Rep. 2022 Feb 7;12(1):2003. doi: 10.1038/s41598-022-05736-4. Sci Rep. 2022. PMID: 35132095 Free PMC article.
New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α-glucosidase enzymes.
Mohammadi-Khanaposhtani M, Nori M, Valizadeh Y, Javanshir S, Dastyafteh N, Moaazam A, Hosseini S, Larijani B, Adibi H, Biglar M, Hamedifar H, Mahdavi M, Kamci H, Karakus A, Taslimi P. Mohammadi-Khanaposhtani M, et al. Among authors: hosseini s. Arch Pharm (Weinheim). 2022 May;355(5):e2100313. doi: 10.1002/ardp.202100313. Epub 2022 Feb 8. Arch Pharm (Weinheim). 2022. PMID: 35132681
3,527 results